HY-113270A-100mg
|
MedChemexpress LLC
|
(3-Carboxypropyl)trimethylammonium chloride [CAS 6249-56-5]
|
|
COVID-19-immunoregulation
|
|
HY-113270A-1mL
|
MedChemexpress LLC
|
(3-Carboxypropyl)trimethylammonium chloride [CAS 6249-56-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-113270AS-10mg
|
MedChemexpress LLC
|
(3-Carboxypropyl)trimethylammonium-d9 (chloride) [CAS 85806-17-3]
|
|
|
|
HY-113270AS-5mg
|
MedChemexpress LLC
|
(3-Carboxypropyl)trimethylammonium-d9 (chloride) [CAS 85806-17-3]
|
|
|
|
HY-106784A-1mg
|
MedChemexpress LLC
|
(E)-Ajoene [CAS 92284-99-6]
|
|
|
|
HY-134082A-10mg
|
MedChemexpress LLC
|
(Z)-Oleyloxyethyl phosphorylcholine [CAS 84601-19-4]
|
|
|
|
HY-134082A-5mg
|
MedChemexpress LLC
|
(Z)-Oleyloxyethyl phosphorylcholine [CAS 84601-19-4]
|
|
|
|
HY-K3007-100mL
|
MedChemexpress LLC
|
0.25% Trypsin-EDTA (1x), phenol red
|
|
|
|
HY-K3007-100mL*5
|
MedChemexpress LLC
|
0.25% Trypsin-EDTA (1x), phenol red
|
|
|
|
HY-138822-10mg
|
MedChemexpress LLC
|
2,3-Diphospho-D-glyceric acid (pentasodium salt) [CAS 102783-53-9]
|
|
|
|
HY-138822-5mg
|
MedChemexpress LLC
|
2,3-Diphospho-D-glyceric acid (pentasodium salt) [CAS 102783-53-9]
|
|
|
|
HY-W040264-1mg
|
MedChemexpress LLC
|
24,25-Dihydrolanosterol [CAS 911660-54-3]
|
|
|
|
HY-W040264-5mg
|
MedChemexpress LLC
|
24,25-Dihydrolanosterol [CAS 911660-54-3]
|
|
|
|
HY-N0026-10mg
|
MedChemexpress LLC
|
2'-Acetylacteoside [CAS 94492-24-7]
|
|
|
|
HY-N0026-20mg
|
MedChemexpress LLC
|
2'-Acetylacteoside [CAS 94492-24-7]
|
|
|
|
HY-N0026-5mg
|
MedChemexpress LLC
|
2'-Acetylacteoside [CAS 94492-24-7]
|
|
|
|
HY-W067358-1g
|
MedChemexpress LLC
|
2-Methylpyrazine [CAS 109-08-0]
|
|
|
|
HY-W067358-500mg
|
MedChemexpress LLC
|
2-Methylpyrazine [CAS 109-08-0]
|
|
|
|
HY-W067358-1mL
|
MedChemexpress LLC
|
2-Methylpyrazine [CAS 109-08-0] (10mM in DMSO)
|
|
|
|
HY-Y1840-100g
|
MedChemexpress LLC
|
3-Methoxyphenol [CAS 150-19-6]
|
|
|
|
HY-Y1840-25g
|
MedChemexpress LLC
|
3-Methoxyphenol [CAS 150-19-6]
|
|
|
|
HY-W010254-500mg
|
MedChemexpress LLC
|
4?-Hydroxy-2?-methylacetophenone [CAS 875-59-2]
|
|
COVID-19-immunoregulation
|
|
HY-W010254-1mL
|
MedChemexpress LLC
|
4?-Hydroxy-2?-methylacetophenone [CAS 875-59-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-133876-10mg
|
MedChemexpress LLC
|
4-Di-16-ASP [CAS 114041-00-8]
|
|
|
|
HY-133876-25mg
|
MedChemexpress LLC
|
4-Di-16-ASP [CAS 114041-00-8]
|
|
|
|